The Role of Host and Fungal Factors in the Commensal-to-Pathogen Transition of Candida albicans

Abstract

Purpose of Review The fungus Candida albicans has evolved to live in close association with warm-blooded hosts and is found frequently on mucosal surfaces of healthy humans. As an opportunistic pathogen, C. albicans can also cause mucosal and disseminated infections (candidiasis). This review describes the features that differentiate the fungus in the commensal versus pathogenic state and the main factors underlying C. albicans commensal-to-pathogen transition. Recent Findings Adhesion, invasion, and tissue damage are critical steps in the infection process. Especially invasion and damage require transcriptional and morphological changes that differentiate C. albicans in the pathogenic from the commensal state. While the commensal-to-pathogen transition has some conserved causes and features in the oral cavity, the female urogenital tract, and the gut, site-specific differences have been identified in recent years. Summary This review highlights how specific factors in the different mucosal niches affect development of candidiasis. Recent evidence suggests that colonization of the gut is not only a risk factor for systemic candidiasis but might also provide beneficial effects to the host.

The Hog1 MAPK substrate governs Candida glabrata-epithelial cell adhesion via the histone H2A variant

“…Further, Cghog1Δ contained increased EPA1 levels, and exhibited higher adherence to Lec2cells [4]. Since elevated adhesin expression may confer an advantage in the iron-rich host gut by promoting host adhesion, and impeding clearance by the host [24,38], we next asked if CgSub2 regulates EPA1 expression. For this, we performed three experiments.…”

Oral Complications from Oropharyngeal Cancer Therapy

“…A diagnosis based solely on Candida colonization cultures may not accurately indicate active candida infection, given the opportunistic and commensal nature of candida species [ 29 ]. Therefore, diagnosis should rely on clinical signs and symptoms.…”

The inhibitory effects of carvacrol, nystatin, and their combination on oral candidiasis isolates

“…These medications can disrupt the microbial equilibrium in areas like the mouth and gastrointestinal tract, paving the way for fungal overgrowth. A disturbed microbiota balance means less competition for Candida, enhancing its ability to proliferate and raising the risk of infection [3,4]. Investigations have illuminated the role of gut microbiota in the onset of candidiasis.…”